The market opened in the red on March 30, 2020, overall volumes in futures & options currently stand at 77.45 lakh contracts with a turnover of Rs. 4,29,040.68 crore.

The market opened in the red on March 30, 2020, overall volumes in futures & options currently stand at 77.45 lakh contracts with a turnover of Rs. 4,29,040.68 crore.

The market opened in the red on March 30, 2020. The previous trading session witnessed the Sensex going down by 131.18 points to end at 29,815.59 and the Nifty was up 18.80 points to close at 8,660.25.

The market opened in the red on March 30, 2020. The previous trading session witnessed the Sensex going down by 131.18 points to end at 29,815.59 and the Nifty was up 18.80 points to close at 8,660.25.

The high to low range of the last week becomes crucial which stands at 7,511 to 9,039 levels. As long as we stay within this range, we can expect the markets to consolidate. Stocks in news: Sun Pharmaceutical, Motherson Sumi systems, Manappuram Finance, NTPC, Delta Corp, Lupin and Laurus Labs.

Welcome to the fresh week on D-Street! The markets ended the last trading session near the day’s low and gave away the entire decent gains post RBI announcement. Over the weekend, if market participants were hoping for some Monday Magic to revive the sentiments on D-Street, which lost its pace after RBI announcement then, they will be certainly disappointed.

Aurobindo Pharma gained around 12 per cent to Rs 406 on Friday after the company informed that it has received an EIR from USFDA for its Hyderabad facility. The company also informed that it has received USFDA approval for its muscle relaxant-Tizanidine Hydrochloride. Soon after this approval, the stock hit an upper circuit of Rs 397.50 per share. 

Dr Reddy’s Laboratories announced that its board of directors have given its approval to the company for borrowing up to Rs 2,000 crore, as part of fund-raising plans. 

A subsidiary of Bajaj Finserv, Bajaj Finance Limited plunged around nine per cent on Friday after New York-based research firm-Bernstein downgraded its stock.

New Fund Offers (NFOs) that are open for subscription.